Arthroscopy versus mini-arthrotomy approach for matrix-induced autologous chondrocyte implantation in the knee: a systematic review. by Migliorini, F et al.




approach for matrix-induced autologous 
chondrocyte implantation in the knee: 
a systematic review
Filippo Migliorini1* , Jörg Eschweiler1, Filippo Spiezia5, Bryan J. M. van de Wall6, Matthias Knobe6, 
Markus Tingart1 and Nicola Maffulli2,3,4 
Abstract 
Background: Matrix-induced autologous chondrocyte implantation (mACI) can be performed in a full arthroscopic 
or mini-open fashion. A systematic review was conducted to investigate whether arthroscopy provides better surgical 
outcomes compared with the mini-open approach for mACI in the knee at midterm follow-up.
Methods: This systematic review was conducted following the PRISMA guidelines. The literature search was per-
formed in May 2021. All the prospective studies reporting outcomes after mACI chondral defects of the knee were 
accessed. Only studies that clearly stated the surgical approach (arthroscopic or mini-open) were included. Only stud-
ies reporting a follow-up longer than 12 months were eligible. Studies reporting data from combined surgeries were 
not eligible, nor were those combining mACI with less committed cells (e.g., mesenchymal stem cells).
Results: Sixteen studies were included, and 770 patients were retrieved: 421 in the arthroscopy group, 349 in the 
mini-open. The mean follow-up was 44.3 (12–60) months. No difference between the two groups was found in terms 
of mean duration of symptoms, age, body mass index (BMI), gender, defect size (P > 0.1). No difference was found in 
terms of Tegner Score (P = 0.3), Lysholm Score (P = 0.2), and International Knee Documentation Committee (IKDC) 
Score (P = 0.1). No difference was found in the rate of failures (P = 0.2) and revisions (P = 0.06).
Conclusion: Arthroscopy and mini-arthrotomy approaches for mACI in knee achieve similar outcomes at midterm 
follow-up.
Level of evidence: II, systematic review of prospective studies.
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Introduction
Focal chondral defects of the knee are common [1]. Hya-
line cartilage is avascular, alymphatic, and hypocellular, 
with low metabolic activity [2–4]. Given these proprie-
ties, the healing process often does not result in restitutio 
ad integrum, and residual defects are common [5, 6]. 
Symptomatic chondral defects are debilitating, and may 
lead to retirement from sports activities [7]. In patients 
with focal chondral defects, surgical treatment is often 
required [8, 9]. For smaller defects, microfractures are 
commonly performed [10–14]. Matrix-induced autolo-
gous chondrocyte implantation (mACI) has been com-
monly used to address bigger defects [15, 16]. During 
mACI, chondrocytes are harvested from a nonweight-
bearing zone of the articular cartilage of the knee in a 
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first surgical session, seeded over a membrane, then 
expanded in  vitro [17, 18]. In a second surgical session, 
the membrane loaded with autologous expanded chon-
drocytes is trimmed to fit the defect size, then placed 
into the defect [19, 20]. This second surgical session can 
be performed arthroscopically or with an arthrotomy in 
a minimally invasive fashion (mini-open). Whether the 
surgical approach influences the surgical outcome of 
mACI in the knee has not been previously investigated. 
Thus, a systematic review was conducted to investigate 
whether arthroscopy provides better surgical outcomes 
compared with the mini-open approach for mACI in 
knee at midterm follow-up. The focus of the present work 




This systematic review was conducted following the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines [21]. The PICOTD 
framework was followed:
• P (Problem): knee chondral defect;
• I (Intervention): mACI;
• C (Comparison): arthroscopy versus mini-open sur-
gery;
• O (Outcomes): clinical scores and complications;
• T (Timing): ≥ 12 months follow-up;
• D (Design): prospective trials.
Data source and extraction
Two authors (**;**) independently conducted the litera-
ture search in January 2021. The main online databases 
were accessed: PubMed, Google scholar, Embase, and 
Scopus. The following keywords were used in combina-
tion: chodral, cartilage, articular, damage, defect, injury, 
chondropathy, knee, pain, matrix-induced, autologous, 
chondrocyte, transplantation, implantation, mACI, ther-
apy, management, surgery, arthroscopy, mini-open, out-
comes. The same authors performed separately the initial 
screening. The full text of the articles of interest was 
accessed. A cross reference of the bibliographies was also 
conducted. Disagreements were debated and solved by a 
third author (**).
Eligibility criteria
All the studies reporting outcomes after mACI for 
knee chondral defects were accessed. According to 
the authors’ language capabilities, articles in English, 
German, Italian, French, and Spanish were eligible. 
Only prospective studies with levels I to II of evidence, 
according to Oxford Centre of Evidence-Based Medi-
cine [22], were considered. Only studies that clearly 
stated the fashion of the surgical approach (arthro-
scopic or mini-open) were included. Procedures other 
than mACI were excluded. Only studies reporting a 
follow-up ≥ 12 months were considered eligible. Animal 
or in vitro studies were not eligible. Studies investigat-
ing other surgical approaches rather than arthroscopic 
or mini-open were not eligible. Studies reporting data 
from combined surgeries were not eligible. Studies 
combining mACI with other less committed cells (e.g., 
mesenchymal stem cells) were not considered. Reviews, 
comments, letters, editorials, and techniques were not 
eligible. Only articles reporting quantitative data under 
the outcomes of interest were considered for inclusion. 
Missing data under the outcomes of interest warranted 
exclusion from the present study. Table  1 displays the 
eligibility criteria.
Data extraction
Two independent authors (**;**) performed data extrac-
tion. Study generalities (author, year, journal, type of 
study) and patient baseline demographic information 
were collected (number of samples and related mean 
BMI and age, duration of the symptoms, duration of the 
follow-up, percentage of female). For every approach, 
the following data were retrieved: Lysholm Knee Scoring 
Scale [23], Tegner Activity Scale [24], and International 
Knee Documentation Committee (IKDC) [25] Score. 
Data from complications were also collected: rate of fail-
ures and revisions.
Methodology quality assessment
The methodological quality assessment was performed 
by two independent authors (**;**). The risk of bias 
graph tool of the Review Manager Software (The Nor-
dic Cochrane Collaboration, Copenhagen) was used. The 
following risks of bias were evaluated: selection, detec-
tion, attrition, and other source of bias.
Statistical analysis
The statistical analyses were performed with IBM SPSS 
Version 25. Continuous data were reported as mean dif-
ference (MD) and standard deviation. For binary data, 
odds ratio (OR) effect measure was calculated. The confi-
dence interval (CI) was set at 95% in all the comparisons. 
t-Test and χ2 tests were evaluated for continuous and 
binary data, respectively, with P < 0.05 considered statisti-
cally significant.
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Results
Search result
The literature search identified 559 clinical investiga-
tions. Of them, 201 were excluded as they were dupli-
cates. A further 342 articles were excluded because 
they did not fulfill our eligibility criteria: not focused 
on mACI (N = 171), not clearly stating the approach 
(N = 74), retrospective nature of the study design 
(N = 29), performing arthrotomy (N = 27), combined 
with stem cells (N = 13), other (N = 19), not report-
ing quantitative data under the outcomes of interest 
(N = 6), language limitations (N = 3). This left 16 stud-
ies for inclusion in the present investigation: six ran-
domized controlled trials (RCTs) and ten non-RCTs. 
The flowchart of the literature search is shown in 
Fig. 1.
Methodological quality assessment
Given the limited number of included RCTs, the graph 
evidenced moderate risk of selection bias. The risk of 
selection bias of allocation concealment was low. The 
risk of detection bias was moderate, since the out-
come assessments were rarely blinded. The risk of 
attrition and reporting bias were both moderate to 
low, as were the risk of other biases. Concluding, the 
overall review of the authors’ judgments about each 
risk of bias item was low, attesting to this study’s good 
methodological assessment. The risk of bias graph is 
shown in Fig. 2.
Patient demographics
Data from 770 patients were retrieved: 421 in the 
arthroscopy group, 349 in the mini-open group. The 
mean duration of symptoms before the index sur-
gery was 48.6 (26.4–91.2) months. Women accounted 
for 35% (273 of 770) of the sample. The mean age 
of the patients was 34.1 ± 4.6  years, and the mean 
BMI was 25.1 ± 0.8  kg/m2. The mean defect size was 
4.0 ± 1.4   cm2. The mean follow-up was 44.3 (12–60) 
months. No difference between the two groups was 
found in terms of mean duration of symptoms, age, 
BMI, gender, or defect size (P > 0.1). Generalities and 
demographic of the studies are presented in Table 2.
Efficacy of the procedure
At a mean follow-up of 44.3 (12–60) months, all 
PROMs of interest were improved (Table 3): VAS (MD 
−3.2; P = 0.008), Tegner (+2.2; P = 0.001), Lysholm 
(+31.9; P = 0.0002), IKDC (+33.2; P < 0.0001).
Outcomes of interest
No difference was found in terms of Tegner Score 
(MD 0.5; P = 0.3), Lysholm Score (MD 6.9; P = 0.2), 
and IKDC Score (MD 6.8; P = 0.1). Similarly, no differ-
ence was found in the rate of failures (OR 1.4; P = 0.2) 
and revisions (OR 0.1; P = 0.06). Results of the scores 
are presented in Table 4 and those of complications in 
Table 5.
Table 1 Eligibility criteria
Eligibility criteria
Inclusion criteria
 Clinical studies reporting outcomes following mACI for chondral defects of the knee
 English, German, Italian, French, and Spanish languages
 Prospective studies with level I to II of evidence [22]
 Fashion of the surgical approach (arthroscopic or mini-open) clearly stated
 Length of the follow-up ≥ 12 months
 Report quantitative data under the outcomes of interest
Exclusion criteria
 Animal or in vitro studies
 Other surgical approaches rather than arthroscopic or mini-open
 Studies reporting data on combined surgeries
 Studies reporting data on non-mACI procedures
 Studies enhancing mACI with other less committed cells
 Reviews, comments, letters, editorials, and techniques studies
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Discussion
This systematic review was conducted to investigate 
whether arthroscopy provides better surgical out-
comes compared with the mini-open approach for 
mACI in knee at midterm follow-up. According to 
the main findings of the present study, no difference 
was found between the two approaches in terms of 
PROMs. Additionally, at a mean of 44 months follow-
up, no difference was found in the rate of failure and 
revision surgeries.
We were able to identify one study that compared 
open ACI covered by autologous periosteal flap (pACI) 
versus arthroscopic mACI [30]. PACI was performed 
in the fashion described by Bittermber et al. [39]. Dur-
ing arthroscopic mACI, expanded chondrocytes are 
seeded into a three-dimensional hyaluronic acid mem-
brane (Hyaff-11; Fidia Advanced Biopolymers, Abano 
Terme, Italy), producing the scaffold called Hyalo-
graft C. The membrane was then delivered into the 
defect in a “dry” arthroscopy after trimming using a 
Fig. 1 Flowchart of the literature search
Page 5 of 8Migliorini et al. J Orthop Traumatol           (2021) 22:23  
suitable sized cylindrical cutting device. If necessary, 
several grafts can be applied to fill the defect, using an 
arthroscopic impactor. This technique produced better 
results compared with the open pACI in terms of IKDC 
and complications. However, whether this superior-
ity arose from the approach or the surgical technique 
is unclear. The same arthroscopic technique was used 
by Filiardo et  al., who reported very good results [31, 
32]. The same arthroscopic technique using Hyalo-
graft C was compared with a mini-open mACI (22 ver-
sus 39 patients, respectively) [33]. However, they used 
a porcine resorbable collagen I/III membrane for the 
mini-open procedure. They found comparable results 
at 5  years follow-up. There were four failures in the 
arthroscopic group (18.2%) and eight in the mini-open 
group (20.5%), with no statistically significant differ-
ence between them. The arthroscopic group reported 
a greater IKDC (55.9 ± 22.1 versus 67.4 ± 21.5; 
P = 0.05) at 1-year follow-up, with no differences at 
24- and 60-month follow-up. These results suggested 
that the arthroscopic approach allows quicker recov-
ery, but similar outcomes at midterm follow-up. How-
ever, they used two different membrane (Hyalograft C 
versus porcine resorbable collagen I/III membrane). 
Thus, it is unclear whether the quicker recovery seen 
at 12-month follow-up related to the approach or the 
different membrane. Two studies by Ebert et  al. [27, 
28] performed a similar full-arthroscopic procedure: 
after shaving and debridement, the defect was mapped 
in several planes using a graduated arthroscopy probe. 
The membrane was trimmed so as to be slightly over-
sized. At dry arthroscopy, the defect was dried using 
an arthroscopic sucker, and an adrenaline-soaked 
patty was pressed onto the subchondral bone to fur-
ther dry it and prevent bleeding. Using a no-valves 
large-bore arthroscopic cannula, the membrane was 
positioned into the defect. The membrane was suc-
cessively extracted out of the joint, and the size was 
finalized to correctly fit the defect ensuring correctly 
orientation of the graft. The membrane was glued, and 
a Silastic Foley catheter was introduced in the knee. 
The balloon was then inflated with saline for 30  s to 
compress the membrane and to secure it to the defect. 
There were minor variations in the execution of the 
surgical techniques in the arthroscopic group; minor 
variations were also evidenced in the mini-arthrotomy 
group. Indeed, two studies avoid membrane fixation 
[17, 29], while three studies [17, 26, 34, 37] employed 
fibrin glue to fix the graft. In one study, in addition to 
the glue, the membrane was sutured to ensure stabil-
ity [18]. In the mini-open group, one study [29] used 
a resorbable collagen I graft, while five [17, 18, 26, 34, 
37] used a resorbable collagen I/III membrane. Other 
studies enhanced the membrane with chondrocyte 
spheroids (Chondrosphere) [35, 36, 38]. Conclud-
ing, variations were evident both in the arthroscopic 
and mini-arthrotomy groups, and represent the most 
important limitations of the present study. We were 
unable to identify studies that compare arthroscopy 
and mini-open with the same protocol of membrane 
choice and fixation. Overall, the analyses were limited 
to a restricted number of procedures, representing 
another important limitation. The surgical techniques 
presented some minimal differences between authors, 
and cell culture and expansion protocols were 
Fig. 2 Methodological quality assessment
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heterogeneous between studies. Hence, these results 
should be been interpreted within the limitations of 
the present investigation, opening new perspectives 
and challenges to future studies.
Conclusion
Arthroscopy and mini-open approaches for mACI in 
patients with chondral defects of the knee score were 
similar at midterm follow-up.
Table 2 Generalities and patient baseline of the included studies
Author, year Journal Study design Follow-up 
(months)
Approach Patients Female (%) Mean age Mean BMI Mean size  (cm2)




RCT 24 Control group 7 57 32.3 24.1 2.9
Mini-arthrot-
omy
7 57 32.7 24.3 3
Basad et al. 
2010 [17]





40 38 33 25.3
Control group 20 15 37.5 27.3
Basad et al. 
2015 [26]





25 37 32 24
Becher et al. 
2017
J Orthop Surg 
Res
RCT 36 Arthroscopy 25 32 33 24.9 4.8
Arthroscopy 25 16 34 25.6 4.9
Arthroscopy 25 40 34 25.1 5.2
Ebert et al. 2012 
[27]
Arthroscopy Non-RCT 24 Arthroscopy 20 50 34 26.6 2.7
Ebert et al. 2016 
[28]
Am J Sports Med Non-RCT 60 Arthroscopy 31 51 35 26 2.52
Efe et al. 2012 
[29]
Am J Sports Med Non-RCT 24 Mini-arthrot-
omy
15 60 26
Ferruzzi et al. 
2008 [30]
J Bone Joint Surg Non-RCT 60 Control group 48 38 32 6.4
Arthroscopy 50 28 31 5.9
Filardo et al. 
2011 [31]
Am J Sports Med Non-RCT 84 Arthroscopy 62 23 28 2.5
Filardo et al. 
2014 [32]
Am J Sports Med Non-RCT 84 Arthroscopy 131 35 29 24 2.3
Kon el al. 2011 
[33]
Am J Sports Med Non-RCT 61 Arthroscopy 22 32 46 24.7 2.6
58 Mini-arthrot-
omy
39 35 45 25.6 3.1
Marlovits et al. 
2012 [34]
Am J Sports Med Non-RCT 60 Mini-arthrot-
omy
24 12 35 5.1
Niemeyer et al. 
2016 [35]
Am J Sports Med RCT 12 Mini-arthrot-
omy
25 33 33 24.9 4.8
Mini-arthrot-
omy
25 16 34 25.6 4.9
Mini-arthrot-
omy
25 40 34 25.1 5.2
Niemeyer et al. 
2019 [36]




52 36 36 25.7 2.2
Control group 50 44 37 25.8 2
Saris et al. 2014 
[37]
Am J Sports Med RCT 24 Mini-arthrot-
omy
72 37 35 26.2 4.8
Control group 72 33 26.4
Siebold et al. 
2018 [38]
Knee Surg Sports 
Traumatol 
Arthrosc
Non-RCT 34.8 Arthroscopy 30 36 36 23.8 6
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